NewtekOne, Inc.
NEWTNasdaqCIK 1587987FinancialsFiscal year ends Dec 31
Reports and events: 392 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2120:05 ET | 8-K | 2.03 New direct financial obligation; 8.01 Other events | 0001628280-26-066702 |
| 2026-09-1413:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-061720 |
| 2026-08-1420:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-26-057098 |
| 2026-08-1020:16 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-055245 |
| 2026-08-0620:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-054302 |
| 2026-06-1520:06 ET | 8-K | 5.07 Shareholder vote results | 0001628280-26-043167 |
| 2026-06-1213:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-042658 |
| 2026-05-0820:02 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001587987-26-000004 |
| 2026-04-3020:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-028891 |
| 2026-04-2920:04 ET | 8-K | 2.03 New direct financial obligation; 8.01 Other events | 0001628280-26-028356 |
| 2026-04-2418:11 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0001628280-26-027133 |
| 2026-04-0620:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-023892 |
| 2026-04-0319:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-26-023604 |
| 2026-03-1821:09 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-26-019493 |
| 2026-03-1316:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-017574 |
| 2026-03-1020:41 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-016503 |
| 2026-02-1921:07 ET | 8-K | 2.03 New direct financial obligation; 8.01 Other events | 0001628280-26-009728 |
| 2026-01-2921:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-004111 |
| 2026-01-2914:22 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-26-003992 |
| 2026-01-2621:37 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-003421 |
| 2026-01-2122:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-002929 |
| 2026-01-1212:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-001749 |
| 2026-01-0813:32 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-001282 |
| 2025-12-1014:43 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-056246 |
| 2025-12-0121:20 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-054452 |
| 2025-12-0118:54 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-054386 |
| 2025-11-0719:56 ET | 8-K | 8.01 Other events | 0001628280-25-050585 |
| 2025-11-0719:46 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-050582 |
| 2025-10-2920:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-047106 |
| 2025-09-3013:37 ET | 8-K | 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-043174 |
| 2025-09-3012:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-043166 |
| 2025-09-2921:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-043139 |
| 2025-09-2218:46 ET | SCHEDULE 13D | Ownership report, active investor | 0001104659-25-092081 |
| 2025-09-1812:12 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001587987-25-000169 |
| 2025-09-1720:03 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001587987-25-000166 |
| 2025-08-2620:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001587987-25-000161 |
| 2025-08-2112:23 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001587987-25-000157 |
| 2025-08-1415:55 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001587987-25-000149 |
| 2025-08-0820:03 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001587987-25-000141 |
| 2025-07-2820:08 ET | 8-K | 2.02 Results of operations | 0001587987-25-000127 |
| 2025-06-2512:40 ET | 8-K | 2.02 Results of operations | 0001587987-25-000115 |
| 2025-06-1620:57 ET | 8-K | 5.07 Shareholder vote results | 0001587987-25-000109 |
| 2025-06-0621:19 ET | 8-K | 1.01 Entry into a material agreement | 0001587987-25-000106 |
| 2025-05-1220:15 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001587987-25-000084 |
| 2025-05-0620:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001587987-25-000077 |
| 2025-04-2415:24 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001587987-25-000073 |
| 2025-04-2316:06 ET | 8-K | 2.02 Results of operations | 0001587987-25-000071 |
| 2025-04-2312:34 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001587987-25-000069 |
| 2025-04-0922:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001587987-25-000065 |
| 2025-04-0121:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001587987-25-000062 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.